Intellectual Property Throughout the Drug Development Lifecycle:
Opportunities and Challenges
July 17 | Washington, DC
Course Level: Advanced
This conference was a must-attend for stakeholders in the IP community. Speakers addressed the intellectual property issues most important to patent litigators and in-house counsel in the pharmaceutical industry as well as the critical regulatory issues affecting the pharmaceutical industry. This conference addressed relevant IP topics, including patent, trademark and copyright issues throughout the drug development lifecycle—from pre-clinical development to post-marketing protection and enforcement. The subject was timely for professionals working with both brand and generic pharmaceutical companies. The implementation, maintenance, and defense of the exclusivity of these IP rights is one of the most significant legal and business issues in this era of evolving patent standards.
This conference was designed for professionals in regulatory affairs, legal, and marketing, in the pharmaceutical industry, as well as consulting, pharmacy and management representatives. This conference targeted intellectual property, and more specifically, patent attorneys.